BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8632353)

  • 1. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression.
    Gogas KR; Levine JD; Basbaum AI
    J Pharmacol Exp Ther; 1996 Feb; 276(2):801-9. PubMed ID: 8632353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intrathecal BAM22 on noxious stimulus-evoked c-fos expression in the rat spinal dorsal horn.
    Zeng X; Huang H; Hong Y
    Brain Res; 2004 Dec; 1028(2):170-9. PubMed ID: 15527742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
    Lee IO; Seo Y
    Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
    Gogas KR; Presley RW; Levine JD; Basbaum AI
    Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.
    Hammond DL; Presley R; Gogas KR; Basbaum AI
    J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine.
    Gogas KR; Cho HJ; Botchkina GI; Levine JD; Basbaum AI
    Pain; 1996 Apr; 65(1):9-15. PubMed ID: 8826484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal pre-administration of fentanyl effectively suppresses formalin evoked c-Fos expression in spinal cord of rat.
    Nakamura T; Takasaki M
    Can J Anaesth; 2001 Nov; 48(10):993-9. PubMed ID: 11698319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ACTH on the expression of somatostatin and c-fos in the spinal cord and formalin evoked pain response].
    Wu Q; Li XC; Ruan HZ; Li HD
    Sheng Li Xue Bao; 1999 Feb; 51(1):60-4. PubMed ID: 11972177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C is partly involved in c-fos protein expression of nocuously-activated neurons but may not in concomitant modulatory action through opioid receptors at the spinal level in rats.
    Nie H; Wang H; Zhang RX; Gao WC; Qiao JT
    Sheng Li Xue Bao; 2004 Aug; 56(4):455-60. PubMed ID: 15322678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between post-surgical pain behaviors and spinal Fos-like immunoreactivity in the rat.
    Zhu CZ; Nikkel AL; Martino B; Bitner RS; Decker MW; Honore P
    Eur J Pharmacol; 2006 Feb; 531(1-3):108-17. PubMed ID: 16438960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
    Honoré P; Chapman V; Buritova J; Besson JM
    J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of corticotropin on formalin-evoked c-fos expression of spinal cord and receptors analysis in rat].
    Li HD; Li XC; Ruan HZ
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):394-6. PubMed ID: 10375794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain.
    Hu JY; Jin GZ
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):193-200. PubMed ID: 10452091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mu-opioid receptors in thalamic nucleus submedius depresses bee venom-evoked spinal c-Fos expression and flinching behavior.
    Feng J; Huo FQ; Jia N; Qu CL; Liu J; Li YQ; Tang JS
    Neuroscience; 2009 Jun; 161(2):554-60. PubMed ID: 19341781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in opioid-mediated pain inhibitory mechanisms during the interphase in the formalin test.
    Gaumond I; Spooner MF; Marchand S
    Neuroscience; 2007 Apr; 146(1):366-74. PubMed ID: 17306464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.